Desk›Healthcare› Hester Biosciences Ltd
Hester Biosciences Ltd
BSE 524669 · NSE HESTERBIO · ISIN INE782E01017 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹2,299.00
-2.31%
BSE close, 28 August 2026
₹1,955.73 cr
0.9 cr shares · Micro cap
₹885.00 cr
as published
33.2× · 6.01×
EPS ₹69.32 · BV ₹382.53
292.14 / 52.10
₹ cr, as filed
17
4 selected · 24%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -13.9% |
|---|---|
| Against 52-week low | +83.8% |
| Day change | -2.31% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹69.32 |
|---|---|
| Price / earnings | 33.17× |
| Price / book | 6.01× |
| Book value — derived, price ÷ P/B | ₹382.53 |
| Return on equity | 18.13% |
| Operating margin | 35.83% |
| Net margin | 20.25% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 18.12%
- ROE as published
- 18.13%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 72.66 | 14.71 | 17.29 | 35.83% | 20.25% |
| Mar-26 · Q | 93.71 | 26.38 | 31.01 | 45.50% | 28.15% |
| FY25-26 | 292.14 | 52.10 | 61.24 | 29.82% | 17.83% |
Quarter on quarter
- Revenue, quarter on quarter
- -22.5%
- Net profit, quarter on quarter
- -44.2%
- Operating margin, quarter on quarter
- -967 bps
Disclosure profile 17 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Credit Rating | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| General | 3 |
| Postal Ballot | 3 |
| AGM / EGM | 2 |
| Analyst / Investor Meet | 1 |
| Board Meeting | 1 |
| Newspaper Publication | 1 |
| Outcome | 1 |
| Trading Window | 1 |
| Procedural sub-total | 13 |
| Total | 17 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
17 filings · 4 selected · busiest 2026-07-30
Filing rhythm · the twelve most recent
2026-07-302026-10-06
SelectedProcedural
Filings
17 in the window · 11 earlier on record
-
6 October 2026 ·
Disclosure Under Regulation 30 Of The SEBI Listing Regulations For Investment In Limited Liability Partnership For Group Captive Power Generation
Disclosure under Regulation 30 of the SEBI Listing Regulation for Investment in Limited Liability Partnership for Group Captive Power Generation
Company Update / General View filing →
-
6 October 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held Today
Outcome of Board Meeting and Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for Investment in Limited Liability Partnership ....
Others / Outcome without intimation View filing →
-
25 September 2026 ·
Closure of Trading Window
Closure of Trading Window
Insider Trading / SAST / Closure of Trading Window View filing →
-
4 September 2026 ·
Shareholders' Approval For Reclassification From 'Promoter And Promoter Group' Category To 'Public' Category Shareholders
Shareholders' approval for Reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from Promoter and Promoter Group category to Public Category shareholders of the Company.
Company Update / General View filing →
-
4 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizer's Report for Postal Ballot Process
AGM/EGM / Postal Ballot View filing →
-
4 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Outcome, proceedings and Voting Results of Postal Ballot Process for the Notice dated 30 July 2026
AGM/EGM / Postal Ballot View filing →
-
27 August 2026 ·
Credit Rating
Intimation of Upgrade in Credit Ratings by Care Ratings Limited
Company Update / Credit Rating View filing →
-
4 August 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice
AGM/EGM / Postal Ballot View filing →
-
31 July 2026 ·
Launch Of Interactive Microsite Of 39Th Annual Report FY 2025-26
Launch of Interactive Microsite of 39th Annual Report FY 2025-26
Company Update / General View filing →
-
31 July 2026 ·
Newspaper Publication
Newspaper Clippings of Q1 FY27 Financial Results publication
Company Update / Newspaper Publication View filing →
-
30 July 2026 ·
Analyst / Investor Meet - Outcome
Audio recording of the Earnings Conference Call held on 30 July 2026
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Press Release / Media Release
20260730 Q1 FY27 Press Release
Company Update / Press Release / Media Release View filing →
-
30 July 2026 ·
Financial Results For The Quarter Ended 30 June 2026
Financial Results and Press Release for the Quarter ended 30 June 2026
Result / Financial Results View filing →
-
30 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On 30 July 2026
Outcome of Board Meeting held today
Board Meeting / Outcome of Board Meeting View filing →
-
23 July 2026 ·
Board Meeting Intimation for Financial Results
Hester Biosciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the unaudited standalone ....
Board Meeting / Board Meeting View filing →
-
21 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Voting Results of 39th Annual General Meeting and Scrutiniser Report
AGM/EGM / AGM View filing →
-
21 July 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 39th Annual General Meeting, Voting Results and Scrutinizer Report of the Company
AGM/EGM / AGM View filing →
RSS feed for Hester Biosciences Ltd · the 50 most recent filings